(Q33286060)

25 July 2017

title

Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery (English)

1 reference

25 July 2017

A K Bhatnagar

1

1 reference

25 July 2017

D Kondziolka

series ordinal

2

1 reference

25 July 2017

L Dade Lunsford

series ordinal

3

1 reference

25 July 2017

John C Flickinger

series ordinal

4

1 reference

25 July 2017

publication date

1 June 2007

1 reference

Technology in Cancer Research and Treatment

25 July 2017

published in

1 reference

25 July 2017

volume

6

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

153-160

1 reference

Breast cancer with synchronous metastases: trends in survival during a 14-year period

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Aromatase inhibitors in early breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Stereotactic radiosurgery of the brain using the first United States 201 cobalt-60 source gamma knife

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Stereotactic radiosurgery for four or more intracranial metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Regression and recursive partition strategies in the analysis of medical survival data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Radiosurgery for brain metastases: who may not benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Temozolomide for treating brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Management strategies for patients with brain metastases: has radiosurgery made a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Chemotherapy for the treatment of metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Treatment of brain metastases from melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

The role of neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Brain metastasis responding to gefitinib alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600301

10.1177/153303460700600301

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference